Calamos Advisors »

Adaptive Biotechnologies Cor shares owned by Calamos Advisors

Quarter-by-quarter ownership of Adaptive Biotechnologies Cor (ADPT) shares owned by Calamos Advisors from 13F filings

Historical chart of Calamos Advisors investment in Adaptive Biotechnologies Cor

Tip: Access up to 7 years of quarterly data

All positions including Adaptive Biotechnologies Cor held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adaptive Biotechnologies Cor by Calamos Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.1M 210k 14.96
2025-06-30 $2.5M 215k 11.65
2025-03-31 $1.0M 141k 7.43

More positions owned by Calamos Advisors

NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Western Digital Corp Note 3.000%11/1 (Principal)
Visa Com Cl A (V)
Boeing Dep Conv Pfd A (BA.PA)

View all positions for Calamos Advisors

Top funds holding Adaptive Biotechnologies Cor

Viking Global Investors
BlackRock
Vanguard Group
Ameriprise Financial
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Geode Capital Management
ARK Investment Management
Aristotle Atlantic Partners
State Street Corporation
Driehaus Capital Management
Fred Alger Management
Arrowstreet Capital, Limited Partnership
Blue Water Life Science Advisors
Macquarie Group

View all funds holding Adaptive Biotechnologies Cor